These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11263958)

  • 1. Acute doxorubicin (adriamycin) dosage does not reduce cardiac protein synthesis in vivo, but decreases diaminopeptidase I and proline endopeptidase activities.
    Zima T; Tesar V; Mantle D; Koll M; Patel V; Richardson PJ; Preedy VR
    Exp Mol Pathol; 2001 Apr; 70(2):154-61. PubMed ID: 11263958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Doxorubicin (Adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities.
    Zima T; Tesar V; Richardson PJ; Mantle D; Preedy VR
    Toxicol Appl Pharmacol; 2001 Mar; 171(3):135-40. PubMed ID: 11243912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and chronic alcohol treatment and their superimposition on lysosomal, cytoplasmic, and proteosomal protease activities in rat skeletal muscle in vivo.
    Koll M; Ahmed S; Mantle D; Donohue TM; Palmer TN; Simanowski UA; Seltz HK; Peters TJ; Preedy VR
    Metabolism; 2002 Jan; 51(1):97-104. PubMed ID: 11782879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute dosage with dexrazoxane, but not doxorubicin, is associated with increased rates of hepatic protein synthesis in vivo.
    Zima T; Tesar V; Sherwood R; Sood A; Au LC; Richardson PJ; Preedy VR
    Toxicol Pathol; 2001; 29(6):591-9. PubMed ID: 11794374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Tri-O-cresyl phosphate (TOCP) on proteolytic enzyme activities in mouse liver in vivo.
    Saleem MA; Williams FM; Wilkins RM; Shakoori AR; Mantle D
    J Environ Pathol Toxicol Oncol; 1998; 17(1):69-73. PubMed ID: 9490322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of acute ethanol dosage on liver and muscle protein metabolism.
    Reilly ME; Mantle D; Salisbury J; Peters TJ; Preedy VR
    Biochem Pharmacol; 2000 Dec; 60(12):1773-85. PubMed ID: 11108792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pirimiphos-methyl on proteolytic enzyme activities in rat heart, kidney, brain and liver tissues in vivo.
    Mantle D; Saleem MA; Williams FM; Wilkins RM; Shakoori AR
    Clin Chim Acta; 1997 Jun; 262(1-2):89-97. PubMed ID: 9204212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes.
    Jeyaseelan R; Poizat C; Baker RK; Abdishoo S; Isterabadi LB; Lyons GE; Kedes L
    J Biol Chem; 1997 Sep; 272(36):22800-8. PubMed ID: 9278441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exposure to the nutritional toxin alcohol reduces brain protein synthesis in vivo.
    Bonner AB; Dalwai S; Marway JS; Preedy VR
    Metabolism; 2003 Apr; 52(4):389-96. PubMed ID: 12701047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol-induced reductions in cardiac protein synthesis in vivo are not ameliorated by treatment with the dihydropyridine calcium channel blocker amlodipine.
    Patel VB; Siddiq T; Richardson PJ; Preedy VR
    Alcohol Clin Exp Res; 2000 May; 24(5):727-32. PubMed ID: 10832915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in myocardial antioxidant enzymes in rats treated with adriamycin.
    Li T; Danelisen I; Singal PK
    Mol Cell Biochem; 2002 Mar; 232(1-2):19-26. PubMed ID: 12030376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in Mrp1 expression and 4-hydroxy-2-nonenal adduction in heart tissue of Adriamycin-treated C57BL/6 mice.
    Jungsuwadee P; Cole MP; Sultana R; Joshi G; Tangpong J; Butterfield DA; St Clair DK; Vore M
    Mol Cancer Ther; 2006 Nov; 5(11):2851-60. PubMed ID: 17121932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of protein synthesis in heart muscle under normal conditions and in the adriamycin-cardiomyopathy.
    Zähringer J
    Klin Wochenschr; 1981 Dec; 59(23):1273-87. PubMed ID: 6171675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adriamycin on the polyribosome and messenger-RNA content of rat heart muscle.
    Zähringer J; Höfling B; Raum W; Kandolph R
    Biochim Biophys Acta; 1980 Jul; 608(2):315-23. PubMed ID: 6156705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and chronic effects of adriamycin on fatty acid oxidation in isolated cardiac myocytes.
    Abdel-aleem S; el-Merzabani MM; Sayed-Ahmed M; Taylor DA; Lowe JE
    J Mol Cell Cardiol; 1997 Feb; 29(2):789-97. PubMed ID: 9140835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo RNA synthesis of the hearts of adriamycin-treated rats.
    Dalbow DG; Jaenke RS
    Cancer Res; 1982 Jan; 42(1):79-83. PubMed ID: 6172196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of propranolol to prevent alcohol-induced reductions in cardiac protein synthesis in vivo.
    Patel VB; Richardson PJ; Preedy VR
    Clin Chim Acta; 2000 Oct; 300(1-2):1-12. PubMed ID: 10958858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of reactive oxygen species in adriamycin and menadione-induced glomerular toxicity.
    Morgan WA; Kaler B; Bach PH
    Toxicol Lett; 1998 Feb; 94(3):209-15. PubMed ID: 9609324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cardiac lipoprotein lipase activity in rats treated chronically with adriamycin.
    Thayer WS
    Life Sci; 1985 Feb; 36(7):635-41. PubMed ID: 3968980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.